Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Selenium for CIPN in Recurrent Ovarian Cancer
NCT04201561Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium selenite in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
sodium selenite
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04201561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201561.